First Trust Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

First Trust Capital Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-265,506	Closed	-$2.67M	–	317
2022 Q4	$2.67M	Buy	265,506 +90,500	+52%	+$901K	0.14%	193
2022 Q3	$1.72M	Buy	175,006 +6	+0%	+$59	0.08%	276
2022 Q2	$1.7M	Buy	+175,000	New	+$1.71M	0.12%	199

Other funds holding ORIA

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

First Trust Capital Management's ORIA Position: Q1 2023 in Review

First Trust Capital Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q1 2023, closing a stake of 265,506 shares — an estimated $2.67M sold.

First Trust Capital Management first reported a position in ORIA in Q2 2022 and held it in 3 quarters. The position peaked at $2.67M in Q4 2022. 49 funds tracked by Wall St. Rank hold ORIA as of Q1 2023.

First Trust Capital Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
First Trust Capital Management sold 265,506 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q1 2023, an estimated $2.67M.
First Trust Capital Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q2 2022 and held it in 3 quarters.
First Trust Capital Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $2.67M in Q4 2022.
49 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q1 2023.

Based on First Trust Capital Management's 13F filing for Q1 2023, filed 12 May 2023.